Insider Transactions in Q4 2021 at Pacira Bio Sciences, Inc. (PCRX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2021
|
Mark Froimson Director |
SELL
Bona fide gift
|
Direct |
400
-6.34%
|
-
|
|
Nov 22
2021
|
Charles Anthony Laranjeira Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+18.25%
|
$330,000
$44.1 P/Share
|
|
Nov 16
2021
|
David M Stack CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+13.75%
|
$150,000
$10.81 P/Share
|
|
Nov 04
2021
|
Roy Winston Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+17.71%
|
$480,000
$48.15 P/Share
|